$CALC
CalciMedica, Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021044001 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.575M $3.119M
YoY Change 14.62%
% of Gross Profit
Research & Development $4.166M $10.72M
YoY Change -61.13%
% of Gross Profit
Depreciation & Amortization $127.0K $190.0K
YoY Change -33.16% 35.71%
% of Gross Profit
Operating Expenses $7.741M $13.84M
YoY Change -44.05%
Operating Profit -$7.741M
YoY Change
Interest Expense $33.00K $117.0K
YoY Change -71.79%
% of Operating Profit
Other Income/Expense, Net $0.00 $56.00K
YoY Change -100.0%
Pretax Income -$7.708M -$13.66M
YoY Change -43.58%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.708M -$5.869M
YoY Change 31.33% -42.81%
Net Earnings / Revenue
Basic Earnings Per Share -$0.36
Diluted Earnings Per Share -$0.36 -$713.3K
COMMON SHARES
Basic Shares Outstanding 21.15M
Diluted Shares Outstanding 21.15M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.59M $17.50M
YoY Change 320.49%
Cash & Equivalents $7.864M $17.50M
Short-Term Investments $65.72M $0.00
Other Short-Term Assets $2.465M $100.0K
YoY Change 2365.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $76.05M $17.70M
YoY Change 329.67%
LONG-TERM ASSETS
Property, Plant & Equipment $2.006M $1.800M
YoY Change 11.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.628M
YoY Change
Other Assets $136.0K $3.000M
YoY Change -95.47%
Total Long-Term Assets $6.770M $4.700M
YoY Change 44.04%
TOTAL ASSETS
Total Short-Term Assets $76.05M $17.70M
Total Long-Term Assets $6.770M $4.700M
Total Assets $82.82M $22.40M
YoY Change 269.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.101M $2.200M
YoY Change -4.5%
Accrued Expenses $1.543M $2.300M
YoY Change -32.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.141M $7.200M
YoY Change -42.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.00K
YoY Change
Total Long-Term Liabilities $13.00K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.141M $7.200M
Total Long-Term Liabilities $13.00K $0.00
Total Liabilities $4.154M $7.200M
YoY Change -42.31%
SHAREHOLDERS EQUITY
Retained Earnings -$152.5M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $78.67M -$116.2M
YoY Change
Total Liabilities & Shareholders Equity $82.82M $22.40M
YoY Change 269.74%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$7.708M -$5.869M
YoY Change 31.33% -42.81%
Depreciation, Depletion And Amortization $127.0K $190.0K
YoY Change -33.16% 35.71%
Cash From Operating Activities -$7.785M -$16.93M
YoY Change -54.02% 58.82%
INVESTING ACTIVITIES
Capital Expenditures -$164.0K -$150.0K
YoY Change 9.33% -55.88%
Acquisitions
YoY Change
Other Investing Activities $4.728M $20.10M
YoY Change -76.48%
Cash From Investing Activities $4.564M $19.95M
YoY Change -77.12% -5967.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 497.0K -1.340M
YoY Change -137.09% -13500.0%
NET CHANGE
Cash From Operating Activities -7.785M -16.93M
Cash From Investing Activities 4.564M 19.95M
Cash From Financing Activities 497.0K -1.340M
Net Change In Cash -2.724M 1.680M
YoY Change -262.14% -115.29%
FREE CASH FLOW
Cash From Operating Activities -$7.785M -$16.93M
Capital Expenditures -$164.0K -$150.0K
Free Cash Flow -$7.621M -$16.78M
YoY Change -54.58% 62.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
4628000
CY2020Q4 us-gaap Assets
Assets
101794000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2513000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1356000
CY2020Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
11000
CY2020Q4 us-gaap Liabilities
Liabilities
7008000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
228155000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101794000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133367000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
94786000
CY2020Q2 gray Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
162000
gray Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
56000
CY2020Q2 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
3494000
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
4793000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9363000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19157000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.79
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1379644
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
92000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1129000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-11449000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
4000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
84562000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
495000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1312000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7708000
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
6000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
78667000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-102954000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
226000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7794000
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-110514000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
214000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5869000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-116157000
us-gaap Profit Loss
ProfitLoss
-19157000
us-gaap Profit Loss
ProfitLoss
-13663000
us-gaap Share Based Compensation
ShareBasedCompensation
2441000
us-gaap Share Based Compensation
ShareBasedCompensation
440000
us-gaap Depreciation
Depreciation
247000
us-gaap Depreciation
Depreciation
188000
gray Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
56000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-67000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
17000
gray Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
-193000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1705000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1108000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
49334000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9096000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19946000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
587000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1364000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
587000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25554000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33418000
gray Deferred Offering Costs Included In Accounts Payable And Other Current Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndOtherCurrentLiabilities
9000
gray Property And Equipment Purchases Included In Accounts Payable And Other Current Liabilities
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndOtherCurrentLiabilities
52000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates   </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.68%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates, including those related to accrued research and development expenses, other long-lived assets, stock-based compensation and the valuation of deferred tax assets. </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.68%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company bases its estimates using historical experience, Company forecasts and future plans, current economic conditions, and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources, and adjusts those estimates and assumptions when facts and circumstances dictate.</p>
CY2021Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
7077000
CY2021Q2 gray Short Term Investment Fair Value Disclosure
ShortTermInvestmentFairValueDisclosure
65722000
CY2021Q2 gray Long Term Investment Fair Value Disclosure
LongTermInvestmentFairValueDisclosure
4628000
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
77427000
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
31676000
CY2020Q4 gray Short Term Investment Fair Value Disclosure
ShortTermInvestmentFairValueDisclosure
61615000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
93291000
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2020 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2302000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
425000
CY2020Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
27000
CY2020Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
374000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3128000
CY2020Q4 gray Contractual Termination Obligation
ContractualTerminationObligation
3700000
gray Commitment Expenses Recognized
CommitmentExpensesRecognized
2200000
gray Unpaid Cancellation And Other Related Costs
UnpaidCancellationAndOtherRelatedCosts
0
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
189000
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
176000
us-gaap Operating Lease Expense
OperatingLeaseExpense
352000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
266000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
403000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
205000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
874000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1312000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
214000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2441000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
440000
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
19200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y4M24D
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
3500000
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
4800000

Files In Submission

Name View Source Status
0001564590-21-044001-index-headers.html Edgar Link pending
0001564590-21-044001-index.html Edgar Link pending
0001564590-21-044001.txt Edgar Link pending
0001564590-21-044001-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gray-10q_20210630.htm Edgar Link pending
gray-10q_20210630_htm.xml Edgar Link completed
gray-20210630.xsd Edgar Link pending
gray-20210630_cal.xml Edgar Link unprocessable
gray-20210630_def.xml Edgar Link unprocessable
gray-20210630_lab.xml Edgar Link unprocessable
gray-20210630_pre.xml Edgar Link unprocessable
gray-ex311_6.htm Edgar Link pending
gray-ex312_7.htm Edgar Link pending
gray-ex321_9.htm Edgar Link pending
gray-ex322_8.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending